WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

WHO today approved the decision by the International Steering Committee of the Solidarity Trial to discontinue the hydroxychloroquine and ritonavir arms of the court. In order to find successful COVID-19 care in hospitalized patients, WHO has developed the Solidarity Trial. The International Steering Committee recommended the findings of the Solidarity interim study and reviewed evidences … Read more